Structures by: Roller A.
Total: 139
(E)-1-(2-amino-4.5-dimethoxyphenyl)-3-(4-methoxyphenyl)-prop-2-en-1-one
C18H19NO4
Monatshefte Fur Chemie (2016) 147, 1747-1757
a=13.1460(13)Å b=29.598(3)Å c=8.1392(6)Å
α=90° β=90° γ=90°
(E)-1-(2-aminophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one
C15H13NO2
Monatshefte Fur Chemie (2016) 147, 1747-1757
a=18.877(4)Å b=16.644(3)Å c=19.387(4)Å
α=90° β=91.781(10)° γ=90°
(OC-6-44)-Diamminedichloridomethoxido[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethylcarbamato]platinum(IV)
C8H16Cl2N4O5Pt
Chem. Sci. (2017) 8, 3 2241
a=12.2584(7)Å b=10.9135(6)Å c=21.9058(13)Å
α=90° β=104.6597(18)° γ=90°
(OC-6-44)-Acetatodiamminedichlorido[2-(2,5-dioxopyrrolidin-1-yl)ethyl)carbamato]platinum(IV)
C9H18Cl2N4O6Pt,H2O
Chem. Sci. (2017) 8, 3 2241
a=27.345(5)Å b=10.1753(11)Å c=12.3345(13)Å
α=90° β=101.328(5)° γ=90°
(OC-6-22)-((1R,2R)-diaminocyclohexane)bis(oxalato)platinum(IV)
C10H14N2O8Pt,2(C3H7NO)
Journal of medicinal chemistry (2014) 57, 15 6751-6764
a=8.9059(5)Å b=11.2218(6)Å c=22.0760(11)Å
α=90.00° β=90.00° γ=90.00°
(OC-6-22)-ethane-1,2-diamine(3-methylmalonato)platinum(IV)
C10H16,N2O8Pt,C3H7NO,C3H6O,H2O
Journal of medicinal chemistry (2014) 57, 15 6751-6764
a=13.8623(4)Å b=8.6180(2)Å c=18.7397(5)Å
α=90.00° β=97.8410(10)° γ=90.00°
Dichlorido(1,3,5-Triaza-7-phosphatricyclo[3.3.1.13.7]decane)(h6-benzylammonium)ruthenium(II)
C13H22Cl2N4PRu,CH4O,Cl
Chem. Sci. (2015) 6, 4 2449
a=6.9163(14)Å b=23.660(4)Å c=11.8396(19)Å
α=90.00° β=97.078(9)° γ=90.00°
Dichlorido(1,3,5-Triaza-7-phosphatricyclo[3.3.1.13.7]decane)(h6-N-benzylacetamide)ruthenium(II)
C15H23Cl2N4OPRu
Chem. Sci. (2015) 6, 4 2449
a=10.5379(5)Å b=12.8283(6)Å c=13.7451(7)Å
α=100.766(2)° β=97.279(2)° γ=91.491(2)°
(OC-6-33)-Dichlorido(ethane-1,2-diamine)bis{(4-methoxy)-4- oxobutanoato}platinum(IV)
C12H22Cl2N2O8Pt
Journal of medicinal chemistry (2013) 56, 1 330-344
a=8.2185(3)Å b=10.0375(4)Å c=12.4165(5)Å
α=67.002(3)° β=71.136(2)° γ=84.577(3)°
3-Aminopyridine-2-carbaldehyde thiosemicarbazone
C7H9N5S
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=18.5732(8)Å b=5.5273(2)Å c=17.2799(7)Å
α=90.00° β=90.00° γ=90.00°
Pyridine-2-carbaldehyde N,N-dimethylthiosemicarbazone
C9H12N4S
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=7.3747(2)Å b=7.4532(2)Å c=9.6324(3)Å
α=97.192(2)° β=109.630(2)° γ=95.020(2)°
C14H16GaN10S2,C2H6O,NO3
C14H16GaN10S2,C2H6O,NO3
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=9.3441(7)Å b=9.7491(10)Å c=12.9501(13)Å
α=102.437(6)° β=95.239(5)° γ=96.569(5)°
[Bis(3-aminopyridine-2-carbaldehyde thiosemicarbazonato)- N,N,S-iron(III)] nitrate hydrate
2(C14H16FeN10S2),NO6,NO3,4(H2O)
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=9.2033(4)Å b=23.0998(11)Å c=21.2104(8)Å
α=90.00° β=92.473(3)° γ=90.00°
Methyl (2S)-hydroxy-2-(2-oxo-(4R),(6R)-diphenyl-1,3,2-dioxaphosphorinan-2-yl) acetate
C18H19O6P
Organic & biomolecular chemistry (2013) 11, 42 7420-7426
a=9.7943(4)Å b=10.0856(4)Å c=17.1604(8)Å
α=90.00° β=90.00° γ=90.00°
Methyl (2R)-hydroxy-2-(2-oxo-(4R),(6R)-diphenyl-1,3,2-dioxaphosphorinan-2-yl) acetate
2(C18H19O6P),CH2Cl2
Organic & biomolecular chemistry (2013) 11, 42 7420-7426
a=10.9242(3)Å b=9.4730(3)Å c=18.5505(6)Å
α=90.00° β=94.287(2)° γ=90.00°
(+-)-(1R,2S)-Diethyl 3,3,3-trifluoro-1,2-dihydroxypropylphosphonate
C7H14F3O5P
Organic & biomolecular chemistry (2017) 15, 15 3276-3285
a=10.0601(8)Å b=15.2849(12)Å c=15.3621(11)Å
α=90° β=90.477(3)° γ=90°
2-fluoro-2-(phenylsulfonyl)thietane 1,1-dioxide
C9H9FO4S2
Org. Biomol. Chem. (2017)
a=12.7355(6)Å b=9.6324(4)Å c=9.0837(4)Å
α=90° β=102.2020(10)° γ=90°
2,6-dibenzyltetrahydro-2H-thiopyran 1,1-dioxide
C19H22O2S
Org. Biomol. Chem. (2017)
a=17.0370(10)Å b=10.9283(10)Å c=8.8054(6)Å
α=90° β=90° γ=90°
(1,1-dioxido-2,4-thietanediyl)bis{[4-(trifluoromethyl)phenyl]}
C19H12F6O4S
Org. Biomol. Chem. (2017)
a=8.8749(15)Å b=6.3714(12)Å c=15.789(3)Å
α=90° β=95.698(6)° γ=90°
(1,1-dioxido-2,4-thietanediyl)bis{[4-(trifluoromethyl)phenyl]}
C19H12F6O4S
Org. Biomol. Chem. (2017)
a=6.9602(6)Å b=31.951(3)Å c=8.3374(7)Å
α=90° β=103.572(4)° γ=90°
[(Chlorido)(1,3-dioxo-kO1-1,3-dihydro-2H-inden-2-ylidene)((2-(naphthalen-1-yl)ethyl)amino)methanolato-kO2)](c6-p-cymene)ruthenium(II)
C32H30ClNO3Ru,0.67(H2O)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 32 12040-12049
a=20.9813(8)Å b=10.3997(4)Å c=14.4831(5)Å
α=90° β=117.7999(10)° γ=90°
[(Chlorido)(1,3-dioxo-kO1-1,3-dihydro-2H-inden-2-ylidene)((2-(naphthalen-1-yl)methyl)amino)methanolato-kO2)](c6-p-cymene)ruthenium(II)
C31H28ClNO3Ru
Dalton transactions (Cambridge, England : 2003) (2019) 48, 32 12040-12049
a=22.1184(8)Å b=10.0442(3)Å c=24.5438(9)Å
α=90° β=105.602(2)° γ=90°
[(kN2-Pyridine)(1,3-dioxo-kO1-1,3-dihydro-2H-inden-2-ylidene)((2-(naphthalen-1-yl)methyl)amino)methanolato-kO2)](c6-p-cymene)ruthenium(II)
C36H33N2O3Ru,F6P
Dalton transactions (Cambridge, England : 2003) (2019) 48, 32 12040-12049
a=13.8315(10)Å b=15.1456(7)Å c=16.7083(11)Å
α=90° β=109.345(2)° γ=90°
C5H24Na2NiO31W6,2(C4H12N),3(H2O)
C5H24Na2NiO31W6,2(C4H12N),3(H2O)
Chemical Communications (2016) 52, 9263-9266
a=9.6825(4)Å b=10.3943(5)Å c=11.7580(6)Å
α=113.7330(12)° β=102.5434(12)° γ=90.4790(12)°
Bis(2-hydroxyethylpyridinium) [(decaaqua)(mu-decavanadato)dicobalt(II)]ate tetrahydrate
Co2H20O38V10,2(C7H10NO),4(H2O)
New Journal of Chemistry (2019) 43, 45 17863
a=9.4219(5)Å b=11.2451(6)Å c=11.9820(7)Å
α=78.5909(17)° β=75.1180(17)° γ=66.3817(17)°
(2-hydroxyethylpyridinium)(ammonium) [(tetraaqua)(bis(2-hydroxyethylpyridine))(mu-decavanadato)dicopper(II)]ate tetrahydrate
C14H26Cu2N2O34V10,4(O),N,C7H10NO
New Journal of Chemistry (2019) 43, 45 17863
a=27.0345(15)Å b=9.9170(5)Å c=20.5851(12)Å
α=90° β=119.341(5)° γ=90°
[Rh (n5-C5Me5)(dmen)Cl](CF3SO3)
C14H27ClN2Rh,CF3O3S
New Journal of Chemistry (2018) 42, 13 11174
a=8.5159(3)Å b=9.7262(4)Å c=24.5900(10)Å
α=90° β=90° γ=90°
[Rh(n5-C5Me5)(pin)Cl](Cl)
2(C16H23ClN2Rh),0.5(C2H8O2),2(Cl)
New Journal of Chemistry (2018) 42, 13 11174
a=8.6742(3)Å b=14.5573(6)Å c=14.6705(6)Å
α=90° β=104.1107(13)° γ=90°
[Rh(n5-C5Me5)(tmeda)Cl](CF3SO3)
3(C16H31ClN2Rh),3(CF3O3S),2(H2O)
New Journal of Chemistry (2018) 42, 13 11174
a=13.0112(4)Å b=37.6730(11)Å c=13.6054(4)Å
α=90° β=91.5748(9)° γ=90°
Ru2Cl2(N1N2-dibutanoylhydrazine)(?6-p-cymene)2
C26H38Cl2N2O2Ru2,2(C2H6O)
New J. Chem. (2017)
a=9.0536(4)Å b=9.0906(4)Å c=9.9218(4)Å
α=88.9010(11)° β=88.7726(11)° γ=85.6563(11)°
Ru2Cl2(N1N2-dibutanoylhydrazine)(?6-p-cymene)2
C28H42Cl2N2O2Ru2,C10H14Cl2Ru
New J. Chem. (2017)
a=9.9160(4)Å b=12.3781(5)Å c=16.9971(7)Å
α=76.1322(15)° β=78.3310(15)° γ=88.3137(16)°
Ru2Cl2(N1N2-dipentanoylhydrazine)(?6-p-cymene)2
C30H46Cl2N2O2Ru2,2(H2O)
New J. Chem. (2017)
a=9.6072(5)Å b=9.7722(5)Å c=17.7727(8)Å
α=95.264(2)° β=90.7653(18)° γ=93.160(2)°
[RuCl(propionylhydrazine)(?6-p-cymene)]Cl
0.5(C13H22N2ORu),1.5(Cl),0.5(C13H22ClN2ORu)
New J. Chem. (2017)
a=13.8233(6)Å b=20.4127(9)Å c=12.0459(5)Å
α=90° β=103.2769(16)° γ=90°
[Fe(p-hydrocoumaric hydroxamate)3]
C27H30FeN3O9,2(H2O)
RSC Advances (2016) 6, 46 40238
a=15.9200(7)Å b=11.6967(5)Å c=15.9254(6)Å
α=90° β=104.5149(15)° γ=90°
[Fe(3-hydroxybenzoic hydroxamate)3]
C21H18FeN3O9,2(C3H6O)
RSC Advances (2016) 6, 46 40238
a=11.1864(4)Å b=21.2415(7)Å c=25.3894(9)Å
α=90° β=90° γ=90°
[Fe2(hypogallic hydroxamate)4Cl2]
C28H24Cl2Fe2N4O16,2(C4H10O),2(CH4O)
RSC Advances (2016) 6, 46 40238
a=12.4686(6)Å b=11.1309(5)Å c=17.4694(10)Å
α=90° β=94.456(3)° γ=90°
[Fe(salicylic hydroxamate)3]
C21H18FeN3O9,1.5(C3H6O)
RSC Advances (2016) 6, 46 40238
a=23.1974(8)Å b=13.7678(8)Å c=22.3320(11)Å
α=90° β=109.575(3)° γ=90°
[Fe(cinammic hydroxamate)3]
C27H24FeN3O6,C1.2H4.4O,0.3(C2H6O)
RSC Advances (2016) 6, 46 40238
a=16.0853(15)Å b=28.696(3)Å c=7.0062(6)Å
α=90° β=96.758(3)° γ=90°
[Fe(eudesmic hydroxamate)3]
C30H36FeN3O15,4(H2O)
RSC Advances (2016) 6, 46 40238
a=12.0485(7)Å b=13.2910(7)Å c=13.4446(7)Å
α=69.9928(19)° β=78.6474(19)° γ=68.339(2)°
C48H43Cl6Fe3NP2
C48H43Cl6Fe3NP2
RSC Adv. (2016)
a=9.1961(5)Å b=18.5027(10)Å c=14.0562(8)Å
α=90° β=96.081(2)° γ=90°
C48H46BBr2Cl4Fe3NP2
C48H46BBr2Cl4Fe3NP2
RSC Adv. (2016)
a=9.3238(3)Å b=18.8630(7)Å c=13.9040(5)Å
α=90° β=97.689(2)° γ=90°
(SFc,SFc)-11
C46H39Br2Fe3NP2,2(CH2Cl2)
RSC Adv. (2016)
a=9.3149(3)Å b=18.7337(7)Å c=13.9965(5)Å
α=90° β=97.3358(14)° γ=90°
(+)-erythro-N-(N-allylthiocarbamoyl) mefloquine, (11R,12S)
C21H21F6N3OS,C2H3N
RSC Adv. (2016)
a=5.75560(10)Å b=15.8271(4)Å c=26.2952(6)Å
α=90° β=90° γ=90°
(-)-erythro-N-(N-allylthiocarbamoyl) mefloquine, (11S, 12R)
C21H21F6N3OS,C2H3N
RSC Adv. (2016)
a=5.76580(10)Å b=15.8201(4)Å c=26.2887(6)Å
α=90° β=90° γ=90°
(2, 3-DAP)-tri-manganese-18-tungstoantimonate
H12K4Mn3O74.5Sb2W19,5.6(H2O),4(C12H11N4)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15651-15655
a=12.116(2)Å b=14.374(3)Å c=21.414(4)Å
α=108.55(3)° β=91.90(3)° γ=99.07(3)°
Krebs-Cadmium-tungstoantimonate
Cd2ClMn2Na6O89.5Sb2W18,4(H2O),2(C4H12N)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15651-15655
a=12.3753(7)Å b=13.6520(8)Å c=17.0910(10)Å
α=70.120(2)° β=83.879(2)° γ=65.614(2)°
Hexa-zinc-18-tungstoantimonate
O72Sb2W17.5Zn6,14(H2O),4(C12H11N4),8.6(O),2(C4H12N),0.5(C24H1
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15651-15655
a=12.4792(8)Å b=17.4813(13)Å c=17.6938(11)Å
α=94.425(4)° β=109.140(3)° γ=104.946(4)°
(TMA)4Hexa-zinc-18-tungstoantimonate
O72Sb2W18Zn6,4(C4H12N)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15651-15655
a=14.5029(12)Å b=23.1699(12)Å c=18.1162(11)Å
α=90° β=95.440(4)° γ=90°
(2, 3-DAP)-di-zinc-18-tungstoantimonate
H12Na5O83Sb2W19.89Zn2.11,4(C12H10.25N4)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 44 15651-15655
a=12.6796(7)Å b=14.1057(7)Å c=20.5025(11)Å
α=92.665(3)° β=93.300(3)° γ=115.147(3)°
[((2-κN)-1H-Indazole)(1-benzyl-4-(2-κC)-phenyl-1,2,3-(3-κN)-triazolato)(η6-p-cymene)ruthenium(II)] nitrate
2(C32H32N5Ru),H2O,2(NO3)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 13 4625-4638
a=10.6875(11)Å b=22.259(2)Å c=25.861(3)Å
α=90° β=90.648(4)° γ=90°
[(S-(Methylsulfanyl)methane)(1-benzyl-4-(2-\?C)-phenyl-1,2,3-(3-\?N)-triazolato)(\?6-p-cymene)ruthenium(II)] nitrate
C27H32N3RuS,NO3
Dalton transactions (Cambridge, England : 2003) (2018) 47, 13 4625-4638
a=9.8204(5)Å b=11.5773(6)Å c=15.0588(9)Å
α=98.178(2)° β=107.253(2)° γ=113.792(2)°
[(κN-1,3-Benzothiazole)(1-benzyl-4-(2-κC)-phenyl-1,2,3-(3-κN)-triazolato)(η6-p-cymene)ruthenium(II)] nitrate
C32H31N4RuS,CH2Cl2,NO3,0.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 13 4625-4638
a=12.0373(8)Å b=13.4469(8)Å c=20.7463(15)Å
α=95.649(2)° β=95.099(3)° γ=98.748(2)°
[(Chlorido)(3-(3-methylbut-2-en-1-yl)-1,4-dioxo-kappaO1-1,4-dihydronaphthalen-2-olato-kappaO2) (p-cymene)ruthenium(II)]
C25H27ClO3Ru
Chem.Commun. (2013) 49, 3348
a=12.8956(5)Å b=11.8913(4)Å c=14.2756(5)Å
α=90.00° β=98.501(2)° γ=90.00°
[(Chlorido)(3-(3-methylbut-2-en-1-yl)-1,4-dioxo-kappaO1-1,4-dihydronaphthalen-2-olato-kappaO2) (p-cymene)osmium(II)]
C25H27ClO3Os
Chem.Commun. (2013) 49, 3348
a=13.4764(4)Å b=8.4120(2)Å c=21.0225(5)Å
α=90.00° β=107.9860(10)° γ=90.00°
Chlorido(hapto^6^-p-cymene){5-oxo-2-((diphenylposhphoramido)methyl)-4H-pyronato}ruthenium(II)]
C28H29ClNO6PRu
Dalton transactions (Cambridge, England : 2003) (2014) 43, 26 9851-9855
a=15.998(3)Å b=16.226(4)Å c=10.5737(18)Å
α=90.00° β=105.258(6)° γ=90.00°
Catena-(sodium-bis(nitromethane)-trans-[tetra-miu-chlorido-bis(1-ethylindazole)ruthenate(III)
C18H20Cl4N4Ru,2(CH3NO2),Na
Dalton transactions (Cambridge, England : 2003) (2015) 44, 2 659-668
a=7.6282(4)Å b=25.0359(15)Å c=7.5616(5)Å
α=90.00° β=110.6095(18)° γ=90.00°
Tetrabutylammonium trans-[tetrachloridobis(1-ethylindazole)ruthenate]acetone solvate
C18H20Cl4N4Ru,C16H36N,2(C3H6O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 2 659-668
a=12.3520(17)Å b=24.580(2)Å c=14.773(2)Å
α=90.00° β=102.934(2)° γ=90.00°
Tetrabutylammonium trans-[tetrachloridobis(1-methylindazole)ruthenate(III)] acetone solvate'
C16H16Cl4N4Ru,0.75(C3H6O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 2 659-668
a=12.1585(5)Å b=23.9977(9)Å c=14.8897(6)Å
α=90.00° β=104.0629(14)° γ=90.00°
[(N,N`-bis(5-triethylammoniummethylsalicylidene)-1,2-ethylenediiminato)nickel(II)] (ClO4)2
C30H46N4NiO2,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 18 7758-7767
a=10.0932(6)Å b=15.4168(8)Å c=22.8812(13)Å
α=90° β=92.2906(17)° γ=90°
[N,N'-bis(5-triethylammoniummethylsalicylidene)-1,2-ethylenediamine](ClO4)2
2(ClO4),C30H48N4O2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 18 7758-7767
a=7.779(6)Å b=8.339(6)Å c=14.025(12)Å
α=75.82(2)° β=81.71(2)° γ=80.21(4)°
[(N,N'-bis(5-triethylammoniummethylsalicylidene)-1,2-ethylenediiminato)copper(II)](ClO4)2
C30H46CuN4O2,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 18 7758-7767
a=9.2787(13)Å b=12.812(2)Å c=16.033(3)Å
α=70.114(8)° β=82.910(7)° γ=87.960(7)°
3-Hydroxy-6-methyl-2-(p-tolyl)-4H-pyran-4-thione
C13H12O2S
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 724-733
a=11.1036(4)Å b=6.9087(2)Å c=14.7366(5)Å
α=90° β=101.0720(13)° γ=90°
Chlorido{3-(oxo-?O)-2(-4-fluorophenyl)-6-methyl-pyran-4(1H)-thionato-?S}(?5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)
C22H23Cl0.25FO2RhS,0.75(Cl)
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 724-733
a=8.0870(5)Å b=8.4811(4)Å c=30.4205(17)Å
α=90° β=90° γ=90°
Chlorido{3-(oxo-?O)-2-(4-methoxyphenyl)-6-methyl-pyran-4(1H)-thionato-?S}(?5-1,2,3,4,5 pentamethylcyclopentadienyl) rhodium(III)
C23H26ClO3RhS,C3H7
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 724-733
a=27.7598(10)Å b=8.3099(3)Å c=22.7034(9)Å
α=90° β=105.2325(11)° γ=90°
Chlorido{3-(oxo-?O) 2-(4-methoxyphenyl)-6-methyl-pyran-4(1H)-thionato-?S}(?6-p-cymene)ruthenium(II)
C23H25ClO3RuS
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 724-733
a=12.9626(4)Å b=13.7228(5)Å c=14.0458(5)Å
α=94.2722(13)° β=107.0275(12)° γ=107.9291(12)°
C22H23ClO3Ru
C22H23ClO3Ru
Dalton transactions (Cambridge, England : 2003) (2016) 45, 33 13091-13103
a=15.5644(8)Å b=7.9491(4)Å c=15.7175(8)Å
α=90° β=100.110(2)° γ=90°
Chlorido[2-Butyl-(3-oxo-?O)-[1,4]-naphthoquinonato- ?O4] ](h6-p-cymene)ruthenium(II)
C24H27ClO3Ru
Dalton transactions (Cambridge, England : 2003) (2016) 45, 33 13091-13103
a=9.3210(15)Å b=15.229(3)Å c=17.358(3)Å
α=93.711(6)° β=92.771(5)° γ=91.845(5)°
C13H13NO3
C13H13NO3
Dalton transactions (Cambridge, England : 2003) (2016) 45, 33 13091-13103
a=11.8478(4)Å b=6.9261(2)Å c=13.7030(4)Å
α=90° β=98.488(2)° γ=90°
C22H24ClNO3Ru
C22H24ClNO3Ru
Dalton transactions (Cambridge, England : 2003) (2016) 45, 33 13091-13103
a=18.3763(6)Å b=9.2791(3)Å c=23.9785(8)Å
α=90° β=98.607(2)° γ=90°
Sodium-copper(II) paratungstateB
Cu3H36Na4O64W12,4(H2O)
Acta Crystallographica Section C (2018) 74, 11
a=10.6516(5)Å b=12.7532(6)Å c=13.0730(5)Å
α=113.7710(10)° β=90.4430(10)° γ=112.5020(10)°
Sodium-iron(II) pararungstateB
Fe2.5H54Na5O71W12,7(H2O)
Acta Crystallographica Section C (2018) 74, 11
a=12.3758(6)Å b=14.7752(7)Å c=18.8919(8)Å
α=92.9341(14)° β=100.6938(14)° γ=94.1698(15)°
C13H17AlMo6NO25,4.73(H2O),3(CH4O),2(C16H36N),C16H35.5N,C9H7N
C13H17AlMo6NO25,4.73(H2O),3(CH4O),2(C16H36N),C16H35.5N,C9H7N
Acta Crystallographica Section C (2018) 74, 11
a=16.1062(17)Å b=26.512(3)Å c=45.569(5)Å
α=90° β=90° γ=90°
C23H25AlClMo6N2O27,9(H2O),2(C16H36N),C16H35N
C23H25AlClMo6N2O27,9(H2O),2(C16H36N),C16H35N
Acta Crystallographica Section C (2018) 74, 11
a=21.8904(6)Å b=23.9848(6)Å c=37.7190(10)Å
α=90° β=90° γ=90°
3-Amino-5-methyl-5-(4-pyridyl)hydantoin
C9H10N4O2
Acta Crystallographica Section E (2009) 65, 5 o953
a=12.8282(5)Å b=12.8282(5)Å c=22.9016(17)Å
α=90.00° β=90.00° γ=90.00°
Alpha dodecatungstochromate(III)
Cr0.6O40W12
Journal of the American Chemical Society (2020)
a=15.0892(6)Å b=21.1101(6)Å c=13.0805(4)Å
α=90° β=98.788(2)° γ=90°
Ethyl (+-)-2-(((2R*,6R*)-4,4-dimethyl-2-oxido-6-phenyl -1,3,2-dioxaphosphinan-2-yl)oxy)-acrylate
C16H21O6P
The Journal of organic chemistry (2017) 82, 19 10310-10318
a=7.5159(2)Å b=8.9376(3)Å c=12.5585(4)Å
α=97.1640(10)° β=94.7880(10)° γ=92.485(2)°
N-(3-diazo-2-oxopropyl)-4-methyl-N-phenylbenzenesulfonamide
C16H15N3O3S
The Journal of organic chemistry (2018) 83, 8 4336-4347
a=34.532(7)Å b=5.4982(11)Å c=24.983(5)Å
α=90° β=128.57(3)° γ=90°
N-(3-diazo-2-oxopropyl)-4-methyl-N-phenylbenzenesulfonamide
C16H15N3O3S
The Journal of organic chemistry (2018) 83, 8 4336-4347
a=27.520(6)Å b=5.4702(11)Å c=21.104(4)Å
α=90° β=90° γ=90°
(S,Rp)-(-)-Methyl N-t-butoxycarbonyl-N-(1-phenylethyl)-hydroxymethylphosphonamidate
C15H24NO5P
The Journal of organic chemistry (2015) 80, 2 1082
a=8.1416(4)Å b=12.3151(6)Å c=16.6694(8)Å
α=90.00° β=90.00° γ=90.00°
(R,Rp)-(+)-Methyl (1-t-butoxycarbonylamino-1-phenylethyl)-(hydroxymethyl)phosphinate
C15H24NO5P
The Journal of organic chemistry (2015) 80, 2 1082
a=6.1460(2)Å b=9.9844(4)Å c=27.1630(11)Å
α=90.00° β=90.00° γ=90.00°
(R*,Sp*)-(+/-)-methyl [1-(t-butoxycarbonylamino)-3-methylbutyl]-(acetoxymethyl)phosphinate
C14H28NO6P
The Journal of organic chemistry (2015) 80, 2 1082
a=11.9276(10)Å b=13.6030(13)Å c=11.5725(11)Å
α=90.00° β=100.976(4)° γ=90.00°
(S*,Sp*)-(+/-)-methyl N-Boc-N-(1,2,3,4-tetrahydronaphthalen-1-yl)- hydroxymethylphosphonamidate
C17H26NO5P
The Journal of organic chemistry (2015) 80, 2 1082
a=16.6200(7)Å b=12.9107(6)Å c=18.0311(8)Å
α=90.00° β=110.184(2)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- ruthenium(II)} chloride ethanol solvate
C32H30Cl2N5Ru,C2H6O,Cl
Organometallics (2011) 30, 2 273-283
a=10.7350(4)Å b=12.0515(4)Å c=25.1678(9)Å
α=90.00° β=94.293(2)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- ruthenium(II)} chloride
C31H28Cl2N5Ru,Cl
Organometallics (2011) 30, 2 273-283
a=26.5354(10)Å b=26.5354(10)Å c=9.0872(4)Å
α=90.00° β=90.00° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-methyl-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- osmium(II)} chloride hydrate
C33H33ClN5Os,0.5(O2),Cl
Organometallics (2011) 30, 2 273-283
a=11.690(2)Å b=21.276(4)Å c=25.898(4)Å
α=90.00° β=102.712(9)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- osmium(II)} chloride diethyl ether water solvate
4(C31H28Cl2N5Os),2(C2H5O2),O3,4(Cl)
Organometallics (2011) 30, 2 273-283
a=17.2834(5)Å b=14.0348(5)Å c=29.4680(11)Å
α=90.00° β=106.416(4)° γ=90.00°
{(hapto^6^-p-cymene)[N-(5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- ruthenium(II)} chloride hydrate
C32H31ClN5Ru,0.2(O4),Cl,0.9(O)
Organometallics (2011) 30, 2 273-283
a=10.4899(3)Å b=11.8881(3)Å c=25.1390(8)Å
α=90.00° β=95.195(2)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-methyl-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- ruthenium(II)} chloride
C34H36.4Cl2N5O0.7Ru
Organometallics (2011) 30, 2 273-283
a=10.6834(11)Å b=12.0598(12)Å c=25.482(3)Å
α=90.00° β=93.080(7)° γ=90.00°
Trans-[Dichloridotetrakis(imidazole)ruthenium(III)]chloride
C12H16Cl3N8Os
Inorganic Chemistry (2008) 47, 7338-7347
a=9.6110(3)Å b=18.9329(9)Å c=9.6818(3)Å
α=90.00° β=90.016(2)° γ=90.00°
Cis-[Dichloridotetrakis(imidazole)ruthenium(III)]chloride
C12H16Cl3N8Os
Inorganic Chemistry (2008) 47, 7338-7347
a=11.229(2)Å b=12.259(3)Å c=7.0080(14)Å
α=90.00° β=104.11(3)° γ=90.00°
Trans-[Dichloridotetrakis(benzimidazole)ruthenium(III)] chloride methanol diethyl ether solvate
C33H38Cl3N8O2Os
Inorganic Chemistry (2008) 47, 7338-7347
a=15.7469(4)Å b=13.6976(4)Å c=16.5585(5)Å
α=90.00° β=93.710(2)° γ=90.00°
Trans-[Dichloridotetrakis(indazole)ruthenium(III)]chloride methanol water solvate
C29H30Cl3N8O2Os
Inorganic Chemistry (2008) 47, 7338-7347
a=16.9910(4)Å b=11.1273(4)Å c=16.6057(4)Å
α=90.00° β=97.557(2)° γ=90.00°
Trans-[Dichloridotetrakis(pyrazole)ruthenium(III)]chloride
C12H16Cl3N8Os
Inorganic Chemistry (2008) 47, 7338-7347
a=7.9101(2)Å b=8.4109(2)Å c=14.6494(4)Å
α=102.690(2)° β=90.8860(10)° γ=110.743(2)°
Mer,trans-[Trichloridoindazole-1-(1H-indazol-1-yl)ethanimineruthenium(III) diethyl ether solvate
C20H25Cl3N5ORu
Inorganic Chemistry (2008) 47, 6513-6523
a=21.2476(8)Å b=13.0596(8)Å c=16.8248(6)Å
α=90.00° β=96.347(4)° γ=90.00°
Mer,trans-[Trichloridobis(indazole)(kappa^N3^-N6,N6- dimethyladenineruthenium(III)] tetrahydrofuran solvate
C25H29Cl3N9ORu
Inorganic Chemistry (2008) 47, 6513-6523
a=10.690(2)Å b=12.757(3)Å c=12.957(3)Å
α=116.63(3)° β=103.45(3)° γ=103.08(3)°
Mer,trans-[Trichloridoindazole-1-(1H-indazol-1-yl-1- phenylmethanimineruthenium(III)] benzonitrile solvate
C28H22Cl3N6Ru
Inorganic Chemistry (2008) 47, 6513-6523
a=9.808(2)Å b=11.927(2)Å c=12.689(3)Å
α=104.96(3)° β=107.96(3)° γ=93.78(3)°
Trans,trans-[Dichlorido-bis(1-(1H-indazol-1-yl)ethanimine)ruthenium(III)] acetonitrile solvate
C20H21Cl3N7Ru
Inorganic Chemistry (2008) 47, 6513-6523
a=9.1416(8)Å b=10.5096(7)Å c=13.0426(12)Å
α=102.157(6)° β=106.752(7)° γ=95.512(6)°
Mer,trans-[Trichloridobis(indazole)methanolruthenium(III)]
C16H20Cl3N4O2Ru
Inorganic Chemistry (2008) 47, 6513-6523
a=8.1718(3)Å b=12.0086(5)Å c=21.2128(8)Å
α=90.00° β=99.626(3)° γ=90.00°
Sodium trans-[tetrachloridobis(indazole)ruthenate(III)] ethyl acetate adduct
C22H28Cl4N4NaO4Ru
Inorganic Chemistry (2008) 47, 6513-6523
a=6.5950(4)Å b=7.7044(4)Å c=14.1038(8)Å
α=75.446(3)° β=83.563(4)° γ=84.134(3)°